| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2007 | US20070021413 Diamino alcohols as therapeutic compounds |
| 01/25/2007 | US20070021412 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (S) 2,3-benzodiazepine |
| 01/25/2007 | US20070021411 Supersaturated benzodiazepine solutions and their delivery |
| 01/25/2007 | US20070021410 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 01/25/2007 | US20070021409 10th Carbon substitution with nitrogen heterocyclic group, halogen, or cycloalkyl or aryl group for use as stable agents against Plasmodium falciparum, Neospora caninum and Eimeria tenella which cause malaria, neosporosis and coccidiosis |
| 01/25/2007 | US20070021408 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021406 New neurokinin antagonists for use as medicaments |
| 01/25/2007 | US20070021404 Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/25/2007 | US20070021403 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021402 Prepared by mixing a lower hydrate of Cefdiner with an aqueous carrier; kits with instructions to mix with water for administration; storage stability |
| 01/25/2007 | US20070021401 Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 01/25/2007 | US20070021400 Amino alcohols as therapeutic compounds |
| 01/25/2007 | US20070021399 Amido-amino alcohols as therapeutic compounds |
| 01/25/2007 | US20070021398 Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/25/2007 | US20070021397 Neurocyte protective agent |
| 01/25/2007 | US20070021396 Oral contraception with trimegestone |
| 01/25/2007 | US20070021395 Compositions for reducing the incidence of drug induced arrhythmia |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021392 Divided dose therapies with vascular damaging activity |
| 01/25/2007 | US20070021391 Preventive/remedy for urinary disturbance |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021389 polymorphs of zoledronic acid and zoledronate sodium salts; monohydrate form; inhibitor of osteoclastic bone resorption |
| 01/25/2007 | US20070021388 trans-stereochemistry to improve half life, oral bioavailability and activity; liver disorderslike liver cancer, liver infections, fibrosis, obesity; trans-4-(3-chlorophenyl)-2-(4-nitrophenoxy)-2-oxo-1,3,2-dioxaphosphorinane |
| 01/25/2007 | US20070021387 Administering a phosphate ester of florfenicol that may be hydrolyzed to form free florfenicol, e.g., 1R,2S-1-(4-Methanesulfonylphenyl)-2-(2,2-dichloroacetylamino)-3-fluoropropyl]-di-tert-butyl phosphate to treat or prevent bacterial infections |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021385 Compositions and methods for wood preservation |
| 01/25/2007 | US20070021384 Compounds for use in the treatment of infection |
| 01/25/2007 | US20070021382 Nitric oxide donors and uses thereof |
| 01/25/2007 | US20070021381 Stabilizing the mutant enzyme by administering a reversible competitive inhibitor consisting an iminosugar, 4-epi-isofagomine or 1-deoxygalactonojirimycin; Gaucher's disease; lysosomal storage diseases |
| 01/25/2007 | US20070021380 Novel drug delivery compositions |
| 01/25/2007 | US20070021379 Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities |
| 01/25/2007 | US20070021378 Heparin compositions and selectin inhibition |
| 01/25/2007 | US20070021377 Pharmaceutical composition comprising a macrolide immunomodulator |
| 01/25/2007 | US20070021376 Supplement composition and method of use in enhancement of methylation process |
| 01/25/2007 | US20070021360 Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase |
| 01/25/2007 | US20070021359 Addition salts of azithromycin and citric acid and process for preparing them |
| 01/25/2007 | US20070021358 Localized delivery of cardiac inotropic agents |
| 01/25/2007 | US20070021357 Treatment of inflammatory conditions |
| 01/25/2007 | US20070021356 Preemptive prophlyaxis of migraine |
| 01/25/2007 | US20070021355 Antidepressants or foods and beverage for antidepression |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070021352 Prevention and treatment of hearing disorders |
| 01/25/2007 | US20070021351 Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor |
| 01/25/2007 | US20070021334 Class III slrp agonists for the reduction of blood vessel formation |
| 01/25/2007 | US20070021333 Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 01/25/2007 | US20070021331 Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/25/2007 | US20070021330 cyclic peptides used as enzyme inhibitors, optionally mixed with carriers or excipients, and viricides selected from interferons, ribavirin and amantadine, for treatment of viral diseases |
| 01/25/2007 | US20070021326 Composition and its Therapeutic Use |
| 01/25/2007 | US20070021325 Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability |
| 01/25/2007 | US20070021323 Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| 01/25/2007 | US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 01/25/2007 | US20070020736 producing an oligosaccharide comprising Neu5Ac alpha -3Gal beta -4Glc; culturing a Lac Y+ and NanT+ Escherichia coli microorganism in a medium comprising precursors consisting of lactose and sialylic acid |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020704 Diaryl ureas with kinase inhibiting activity |
| 01/25/2007 | US20070020682 Use of prion conversion modulating agents |
| 01/25/2007 | US20070020673 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 01/25/2007 | US20070020384 Environmentally benign crop protection agents |
| 01/25/2007 | US20070020352 Treatment modalities for autoimmune diseases |
| 01/25/2007 | US20070020349 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 01/25/2007 | US20070020347 Bioavailability enhancing activity of Carum carvi extracts and fractions thereof |
| 01/25/2007 | US20070020345 Composition for treatment or prevention of a disorder containing Shisandrin B isolated from a Schisandra plant, such as Schisandra chinensis (Fructus schisandrae); may additionally contain herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and/or pH control agents |
| 01/25/2007 | US20070020343 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 01/25/2007 | US20070020342 Non-irritating compositions containing zinc salts |
| 01/25/2007 | US20070020341 pyridoxamine immobilized on the wall a multicompartment cartridge, used for reducing the concentration of carbonyl compounds such as 5-hydroxymethylfurfural, formaldehyde, acetaldehyde or glyoxal, generated during sterilization and storage of peritoneum dialysis solutions containing glucose |
| 01/25/2007 | US20070020340 Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension |
| 01/25/2007 | US20070020339 Compositions and methods for controlling abuse of medications |
| 01/25/2007 | US20070020337 Paclitaxel-based antitumor formulation |
| 01/25/2007 | US20070020336 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 01/25/2007 | US20070020334 Benzimidazole formulation |
| 01/25/2007 | US20070020333 Controlled release of hypnotic agents |
| 01/25/2007 | US20070020332 Tannate compositions, methods of making and methods of use |
| 01/25/2007 | US20070020330 Compositions comprising azelastine and methods of use thereof |
| 01/25/2007 | US20070020329 Methods of formulating linezolid |
| 01/25/2007 | US20070020324 Method and device to treat skin affected by a corn |
| 01/25/2007 | US20070020322 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1, 5-diol |
| 01/25/2007 | US20070020315 Tissue products having low stiffness and antimicrobial activity |
| 01/25/2007 | US20070020309 Safe and effective biofilm inhibitory compounds and health related uses thereof |
| 01/25/2007 | US20070020308 Polymers having covalently bound therapeutic agents |
| 01/25/2007 | US20070020306 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative |
| 01/25/2007 | US20070020299 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/25/2007 | US20070020298 Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| 01/25/2007 | US20070020297 System and method for the treatment of cancer, including cancers of the central nervous system |
| 01/25/2007 | US20070020289 Preparations and processes for stabilizing biological materials by means of drying processes without freezing |
| 01/25/2007 | US20070020282 Monoglycerides; fatty acids; for parenteral or mucosal administration of antigens and/or vaccines to humans and animals |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020263 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 01/25/2007 | US20070020261 Combination therapy of her expressing tumors |
| 01/25/2007 | US20070020254 Methods and compositions for treatment of inflammatory disease |
| 01/25/2007 | US20070020249 Compositions for prevention and treatement of symptoms of gastrointestinal distress |
| 01/25/2007 | US20070020246 Use of microchimeric cells in the treatment of malignancy |
| 01/25/2007 | US20070020241 Use of photosensitisation |
| 01/25/2007 | US20070020239 HEXIMI as a suppressor of HIV replication and cardiac hypertrophy |
| 01/25/2007 | US20070020232 Compositions and methods for cancer immunotherapy |
| 01/25/2007 | US20070020230 Use of chemokines, and pharmaceutical preparations containing the same |
| 01/25/2007 | US20070020228 Method of using a biosealant device |
| 01/25/2007 | US20070020226 Polyacrylamide Hydrogel For The Treatment of Incontinence and Vesicouretal Reflux |
| 01/25/2007 | US20070020224 Protein-proteophore complexes |